Henry Schein, Inc. (NASDAQ:HSIC) COO Michael S. Ettinger Sells 12,240 Shares

Henry Schein, Inc. (NASDAQ:HSICGet Free Report) COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Henry Schein Trading Up 0.2 %

NASDAQ:HSIC opened at $73.91 on Friday. The stock has a market capitalization of $9.21 billion, a price-to-earnings ratio of 30.41, a PEG ratio of 2.15 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a 50 day moving average of $70.68 and a 200 day moving average of $69.69.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the firm posted $1.32 EPS. Henry Schein’s revenue was up .4% on a year-over-year basis. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Evercore ISI upped their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. JPMorgan Chase & Co. reduced their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Robert W. Baird dropped their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and a consensus target price of $78.89.

View Our Latest Research Report on Henry Schein

Hedge Funds Weigh In On Henry Schein

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HSIC. Swedbank AB acquired a new position in shares of Henry Schein in the first quarter valued at about $215,998,000. ING Groep NV acquired a new position in Henry Schein in the 3rd quarter worth approximately $63,226,000. Holocene Advisors LP purchased a new position in Henry Schein during the 3rd quarter worth approximately $58,319,000. Thompson Siegel & Walmsley LLC acquired a new stake in Henry Schein during the 2nd quarter valued at approximately $46,683,000. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Henry Schein in the 3rd quarter valued at $43,740,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.